Qtron Investments’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
2,479
-600
-19% -$110K 0.06% 340
2026
Q1
$581K Buy
3,079
+3
+0.1% +$632 0.08% 306
2025
Q4
$611K Buy
3,076
+2,058
+202% +$416K 0.08% 276
2025
Q3
$207K Buy
+1,018
New +$181K 0.03% 399
2022
Q2
Sell
-6,137
Closed -$528K 434
2022
Q1
$528K Buy
6,137
+479
+8% +$39.4K 0.12% 232
2021
Q4
$462K Buy
+5,658
New +$414K 0.1% 244

Other funds holding THC

Qtron Investments's THC Position: Q2 2026 in Review

Qtron Investments reduced its Tenet Healthcare (THC) stake by 19% in Q2 2026, selling an estimated $110K and leaving 2,479 shares worth $464K. The position accounts for 0.06% of the portfolio, ranked #340.

Qtron Investments first reported a position in THC in Q4 2021 and has held it in 6 quarters since. The position peaked at $611K in Q4 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Qtron Investments held 2,479 shares of Tenet Healthcare worth $464K as of Q2 2026.
  • Qtron Investments sold 600 Tenet Healthcare shares in Q2 2026, an estimated $110K.
  • Tenet Healthcare made up 0.06% of Qtron Investments's portfolio in Q2 2026, its #340 holding.
  • Qtron Investments first reported a position in Tenet Healthcare in Q4 2021 and has held it in 6 quarters since.
  • Qtron Investments's Tenet Healthcare position peaked at $611K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.